Market Overview

Benzinga's Top Upgrades

Share:
Benzinga's Top Upgrades

Analysts at Credit Suisse upgraded Five Below (NASDAQ: FIVE) from “neutral” to “outperform.” The target price for Five Below has been raised from $46 to $52. Five Below's shares closed at $42.72 on Friday.

BB&T Capital upgraded Heartland Express (NASDAQ: HTLD) from “hold” to “buy.” Heartland Express's shares closed at $18.79 on Friday.

Analysts at William Blair upgraded ARIAD Pharmaceuticals (NASDAQ: ARIA) from “market perform” to “outperform.” The target price for ARIAD Pharmaceuticals has been raised from $3 to $12. ARIAD's shares closed at $6.43 on Friday.

JP Morgan upgraded United Therapeutics (NASDAQ: UTHR) from “underweight” to “neutral.” The target price for United Therapeutics has been raised from $62 to $90. United Therapeutics' shares closed at $87.84 on Friday.

Latest Ratings for FIVE

DateFirmActionFromTo
Apr 2019Bank of AmericaInitiates Coverage OnBuy
Apr 2019JP MorganUpgradesNeutralOverweight
Mar 2019Morgan StanleyMaintainsOverweightOverweight

View More Analyst Ratings for FIVE
View the Latest Analyst Ratings

Posted-In: top upgradesUpgrades Analyst Ratings

 

Related Articles (ARIA + FIVE)

View Comments and Join the Discussion!

Latest Ratings

StockFirmActionPT
PEPMorgan StanleyReiterates137.0
AZRXH.C. WainwrightMaintains7.0
PEPMacquarieMaintains138.0
POLBuckinghamMaintains36.0
BKBuckinghamMaintains53.0
View the Latest Analytics Ratings
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Trading Daily
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Daily Analyst Rating
A summary of each day’s top rating changes from sell-side analysts on the street.
Thank You
for registering for Benzinga’s newsletters and alerts.
• The Daily Analysts Ratings email will be received daily between 7am and 10am.
• The Market in 5 Minutes email will be received daily between 7am and 8am.
• The Fintech Focus email will be received every Friday between 2pm and 5pm.

UPDATE: Credit Suisse Reiterates on Ariad Pharmaceuticals as Iclusig Re-Launch is Expected to be Bumpy

Benzinga's Top Initiations